research

Recently, we have seen exciting developments in the antibody-drug conjugate (ADC) space, from cloud computing to radioisotopes.

DAR is key to ADC success. Biointron explains how drug-to-antibody ratios shape potency, safety, and outcomes in cancer therapy.

Learn about dilution buffers in antibody research, their composition, and applications in ELISA, Western blotting, and immunohistochemistry for reliable results.

Antibodies defend health by neutralizing pathogens, aiding phagocytosis, and activating complement. Biointron explains these vital functions in immunity and therapy.

Antibody-drug conjugates unite precision with potency. Biointron outlines how ADCs combine antibodies with cytotoxic drugs to deliver targeted cancer therapies.

Learn about Fab, F(ab')2, and Fc antibody fragments—how they are generated, their roles in antigen targeting, and their evolving applications in biomedical research and therapy.

Single-chain variable fragments (scFvs) combine small size with strong binding. Biointron highlights their history, uses in diagnostics and therapy, and production expertise.

Learn about bispecific antibodies (bsAbs), their history, advantages over monoclonal antibodies, and popular engineering formats like knobs-into-holes and BiTE.

Explore phage display technology for antibody discovery, drug development, and vaccine research, and its role in engineering high-affinity monoclonal antibodies and peptide drugs.

Explore the dual roles of autoantibodies in health and autoimmune diseases, acting as immune defenders and disruptors in lupus, COVID-19, and chronic inflammation.

Combination antibody therapies enhance efficacy by targeting multiple pathways. Biointron showcases synergistic strategies that improve outcomes in cancer and infectious diseases.

Personalized antibody therapies bring precision to treatment. Biointron highlights how monoclonal antibodies and ADCs target cancer, IBD, and other diseases with improved outcomes.

Structure modeling platforms from AlphaFold to Rosetta guide smarter antibody design. Learn strengths, caveats, and how to pair predictions with experimental validation.

Discover how antibody allotypes affect monoclonal antibody immunogenicity and performance, and learn how Biointron supports antibody discovery, engineering, and optimization.

IgE mediates allergy and parasite defense. Learn its biology, clinical significance, and how scientists safely study IgE for new therapeutic opportunities.